Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × zimberelimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Stomach Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Recurrence 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumors 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligometastatic Prostate Cancer 1

Interventions

pembrolizumab 19 Nivolumab 12 avelumab 10 Ipilimumab 7 cemiplimab 5 atezolizumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Radiotherapy 3 Cyclophosphamide 3 prednylidene 2 poly ICLC 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 deltacortene 2 aldesleukin 2 Radiosurgery 2 Prednisone 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 CTLA-4 Antigen 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡